Aurinia Pharmaceuticals (AUPH) had the highest return in 2012 by a US stock or US stock in the Nasdaq Composite (IXIC) with a market cap of $2B+, returning 1,400%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Aurinia Pharmaceuticals (AUPH) | 2012 | 1,400% |
ACADIA Pharmaceuticals (ACAD) | 2012 | 322.73% |
Patrick Industries (PATK) | 2012 | 276.73% |
TG Therapeutics (TGTX) | 2012 | 223.56% |
Regeneron Pharmaceuticals (REGN) | 2012 | 202.72% |
American Airlines (AAL) | 2012 | 159.62% |
Celldex Therapeutics (CLDX) | 2012 | 153.21% |
IES (IESC) | 2012 | 146.63% |
Grifols SA ADR (GRFS) | 2012 | 143.1% |
Acadia Healthcare (ACHC) | 2012 | 137.78% |
Caesars Entertainment (CZR) | 2012 | 121.81% |
Alnylam Pharmaceuticals (ALNY) | 2012 | 119.09% |
Insmed (INSM) | 2012 | 114.42% |
Genmab A-S (GMAB) | 2012 | 114.07% |
Expedia (EXPE) | 2012 | 110.3% |
Addus HomeCare (ADUS) | 2012 | 99.72% |
Dorman Products (DORM) | 2012 | 94.46% |
Option Care Health (OPCH) | 2012 | 93.36% |
IPG Photonics (IPGP) | 2012 | 92.66% |
Seagate Technology (STX) | 2012 | 90.71% |
Madrigal Pharmaceuticals (MDGL) | 2012 | 89.1% |
Repligen (RGEN) | 2012 | 81.5% |
Illumina (ILMN) | 2012 | 79.32% |
Saia (SAIA) | 2012 | 78.81% |
Avis Budget (CAR) | 2012 | 78.56% |